Neurovalens raises £5 million for clinical trials of its neurostimulation tech
The funding will aim to facilitate the company ’s technology to treat conditions such as diabetes, insomnia, anxiety and obesity.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Anxiety | Brain | Clinical Trials | Diabetes | Eating Disorders & Weight Management | Endocrinology | Funding | Information Technology | Insomnia | Neurology | Obesity